Cancer Diagnosis and Molecular Imaging
What is Cancer Diagnosis and Molecular Imaging?
Cancer diagnosis research aims to develop improved technologies and techniques for detecting and characterizing cancer, determining its stage, selecting appropriate treatments, and monitoring patient outcomes. Major areas of focus include discovering and validating diagnostic, prognostic, and predictive biomarkers; improving imaging and molecular profiling to define tumor characteristics; and advancing integrated diagnosis systems to enable precision oncology.
Accurate diagnosis across all cancer phases, from risk assessment through early detection, localized disease, and late-stage progression, provides vital information guiding timely intervention and optimal care for better outcomes. Ongoing diagnosis monitoring also gives critical insight into treatment efficacy and disease recurrence.
Accurate and early cancer diagnosis is essential for improving patient outcomes through timely intervention. Molecular imaging techniques provide unprecedented insights into tumor biology at cellular and molecular levels to guide personalized cancer management.
NFCR IMPACTS IN CANCER DIAGNOSIS AND MOLECULAR IMAGING RESEARCH
- NFCR provides funding for research correlating novel diagnostic markers with tumor biology and treatment outcomes, expanding cancer characterization for better-informed care.
- NFCR supports studies integrating imaging with genomics, proteomics, and metabolomics to advance diagnostics for localized and recurrent tumors.
- Through its seed grant initiatives, NFCR enables proof-of-concept studies on early-stage diagnostic technologies to accelerate development into clinical tools.
NFCR-Supported Researchers Working on Cancer Diagnosis and Molecular Imaging
Himisha Beltran, M.D.
Dana-Farber Cancer Institute
Harvard Medical School
Srinivas Vaswanathan, M.D., Ph.D.
Associate Professor of Medicine, Harvard Medical School
Ritesh R. Kotecha, M.D.
Memorial Sloan Kettering Cancer Center and Weill Cornell Medicine
Christian Rolfo, M.D., Ph.D.
Associate Director Clinical Research, Center for Thoracic Oncology
Icahn School of Medicine at Mount Sinai
Ling Huang, Ph.D.
Pancreatic Cancer Center,
Henry Ford Cancer Institute
Henry Ford Health System
Aditya Bardia, M.D.
Massachusetts General Hospital & Harvard Medical School
James P. Basilion, Ph.D.
Case Western Reserve University
Daniel A. Haber, M.D., Ph.D.
Massachusetts General Hospital Cancer Center
Azra Raza, M.D.
Columbia University
Siddhartha Mukherjee, M.D., D.PHIL
Columbia University
Paul Schimmel, Ph.D.
Scripps Research
Xiang-Lei Yang, Ph.D.
Scripps Research
Robert C. Bast, Jr., M.D.
MD Anderson Cancer Center